<html>
<head>PUBMED IDs for VCX-A</head>
<body bgcolor='#C5F0F2'><h1>VCX-A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10903929/'>A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation.</a> July 25  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12239712/'>FG syndrome: linkage analysis in two families supporting a new gene localization at Xp22.3 [FGS3].</a> September 20  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12955766/'>A familial contiguous gene deletion syndrome at Xp22.3 characterized by severe learning disabilities and ADHD.</a> September 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15001591/'>Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.</a> March 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15733277/'>Xp22.3 microdeletion including VCX-A and VCX-B1 genes in an X-linked ichthyosis family: no difference in deletion size for patients with and without mental retardation.</a> March 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15888481/'>Deletion of VCX-A due to NAHR plays a major role in the occurrence of mental retardation in patients with X-linked ichthyosis.</a> May 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16470742/'>Molecular cytogenetic analysis of a familial interstitial deletion Xp22.2-22.3 with a highly variable phenotype in female carriers.</a> February 14  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17391250/'>Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect.</a> March 30  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17497716/'>First reported case of intrachromosomal cryptic inv dup del Xp in a boy with developmental retardation.</a> May 15  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19812318/'>Modulation of neuritogenesis by a protein implicated in X-linked mental retardation.</a> November 11  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22541287/'>Intellectual disabilities, neuronal posttranscriptional RNA metabolism, and RNA-binding proteins: three actors for a complex scenario.</a> September 15  2012<br></body></html>
